J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 73 (1992), 2375-2383; DOI 10.1099/0022-1317-73-9-2375
© 1992 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, H.
Right arrow Articles by Mach, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, H.
Right arrow Articles by Mach, M.
Agricola
Right arrow Articles by Meyer, H.
Right arrow Articles by Mach, M.

Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies

H. Meyer1, V.-A. Sundqvist2, L. Pereira3 and M. Mach1

1 Institut für Klinische und Molekulare Virologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 7, 8520 Erlangen, Germany
2 Department of Virology, National Bacteriological Laboratory and Karolinska Institute, Stockholm, Sweden
and3 Division of Oral Biology, School of Dentistry, University of California San Francisco, San Francisco, California 94143, U.S.A.

Glycoprotein gp116 of human cytomegalovirus (HCMV) is a target for neutralizing antibodies. Gp116 is a component of the gCI complex which consists of gp58 and gp116. Like its homologue, glycoprotein B of herpes simplex virus type 1, gp116 contains a highly antigenic region in the N-terminal part of the molecule, between amino acids 28 and 84. Prokaryotic expression plasmids and synthetic peptides were used to define binding sites for mouse and human monoclonal antibodies (MAbs) as well as HCMV convalescent sera. Site I, located between amino acids 68 and 77, contains an epitope recognized by the human MAb C23, which is capable of neutralizing HCMV independently of complement and the site is conserved between HCMV strains. Of HCMV-positive human sera, 53% recognized site I. Site II was mapped using mouse MAbs as well as human sera. It is located between residues 50 and 54, an area which is not conserved between strains AD169 and Towne, the two laboratory strains of known sequence. Strain-specific antibodies were detected in 25% of human sera. Site II-specific antibodies, purified from human sera by affinity chromatography, were found to be incapable of neutralizing HCMV in tissue culture.

Received 6 February 1992; accepted 20 May 1992.


This article has been cited by other articles:


Home page
CVIHome page
E. A. Reap, S. A. Dryga, J. Morris, B. Rivers, P. K. Norberg, R. A. Olmsted, and J. D. Chulay
Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins
Clin. Vaccine Immunol., June 1, 2007; 14(6): 748 - 755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. R. McLean, O. A. Olsen, I. N. Watt, P. Rathanaswami, K. B. Leslie, J. S. Babcook, and J. W. Schrader
Recognition of Human Cytomegalovirus by Human Primary Immunoglobulins Identifies an Innate Foundation to an Adaptive Immune Response
J. Immunol., April 15, 2005; 174(8): 4768 - 4778.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. Gicklhorn, M. Eickmann, G. Meyer, M. Ohlin, and K. Radsak
Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion
J. Gen. Virol., July 1, 2003; 84(7): 1859 - 1862.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. Lantto, J. M. Fletcher, and M. Ohlin
A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B
J. Gen. Virol., August 1, 2002; 83(8): 2001 - 2005.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Spaderna, H. Blessing, E. Bogner, W. Britt, and M. Mach
Identification of Glycoprotein gpTRL10 as a Structural Component of Human Cytomegalovirus
J. Virol., February 1, 2002; 76(3): 1450 - 1460.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Speckner, B. Kropff, S. Knör, and M. Mach
The antigenic domain 1 of human cytomegalovirus glycoprotein B contains an intramolecular disulphide bond
J. Gen. Virol., November 1, 2000; 81(11): 2659 - 2663.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. Pepperl, J. Münster, M. Mach, J. R. Harris, and B. Plachter
Dense Bodies of Human Cytomegalovirus Induce both Humoral and Cellular Immune Responses in the Absence of Viral Gene Expression
J. Virol., July 1, 2000; 74(13): 6132 - 6146.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
A. Speckner, D. Glykofrydes, M. Ohlin, and M. Mach
Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization
J. Gen. Virol., August 1, 1999; 80(8): 2183 - 2191.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
M Haber, U Meyer-Konig, and F. Hufert
Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination
J. Gen. Virol., June 1, 1999; 80(6): 1495 - 1500.
[Abstract]


Home page
J. Virol.Home page
M. Klein, K. Schoppel, N. Amvrossiadis, and M. Mach
Strain-Specific Neutralization of Human Cytomegalovirus Isolates by Human Sera
J. Virol., February 1, 1999; 73(2): 878 - 886.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1992 by the Society for General Microbiology.